PATENT CLAIM ANALYSIS

Application Number: 16297133
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["424", "193100"]

Abstract:
A polyplex of a double stranded RNA (dsRNA) and a polymeric conjugate consists of a linear polyethyleneimine (PEI) covalently linked to one or more polyethylene glycol (PEG) moieties. Each PEG moiety is conjugated via a linker to a targeting moiety capable of binding to a cancer antigen. Exemplary cancer antigens include epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2) and prostate surface membrane antigen (PSMA).

Claim (Index 5):
The polyplex of  claim 1 , wherein the cancer antigen is epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2) or prostate surface membrane antigen (PSMA).

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.54545
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15310735', '13237168', '13122667', '14351789', '12134556']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7257935688590503
- 35 USC 102 Novelty (BERT): 0.7303565603712582
- Combined Prediction Score: 0.7262498680102711
- Mean Citation Score: 339.636158
- Max Citation Score: 830.25586
- Similarity Product: 785.359722666372

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test